Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention.

about

Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention.

Item

http://www.wikidata.org/entity/Q52342075

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@en

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@nl

type

Item

label

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@en

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@nl

prefLabel

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@en

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@nl

P1476

Low-Dose Unfractionated Hepari ...... taneous Coronary Intervention.

@en

P2093

Ji Huang

http://www.w3.org/2001/XMLSchema#string

Nan Li

http://www.w3.org/2001/XMLSchema#string

Xue-Jian Hou

http://www.w3.org/2001/XMLSchema#string

Zhao Li

http://www.w3.org/2001/XMLSchema#string

Zhi-Zhong Li

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline

Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.

Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease

Current concepts on coronary revascularization in diabetic patients.

Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).

P304

764-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0366-6999.228251

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29578118

http://www.w3.org/2001/XMLSchema#string

P932

5887733

http://www.w3.org/2001/XMLSchema#string